Axxess Compounding II, LLLP

Amendment

CIK: 0001595664·Pharmaceuticals·MONTANA·Filed: Nov 6, 2014

Total Offering

$25,470,000

Amount Sold

$355,000

Investors

33

First Sale

Oct 8, 2013

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Limited Partnership
Year Incorporated: 2012
Non-Accredited Investors: No

Related Persons

Name	Role
Frances X Riegler	Related Person

Company

Axxess Compounding II, LLLP

3819 STEPHENS AVENUE, #201

MISSOULA, MT, 59801

406-219-7512

SEC Filing

0001595664-14-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.